Your browser doesn't support javascript.
loading
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
Kirchner, Martina; Glade, Julia; Lehmann, Ulrich; Merkelbach-Bruse, Sabine; Hummel, Michael; Lehmann, Annika; Trautmann, Marcel; Kumbrink, Jörg; Jung, Andreas; Dietmaier, Wolfgang; Endris, Volker; Kazdal, Daniel; Ploeger, Carolin; Evert, Matthias; Horst, David; Kreipe, Hans; Kirchner, Thomas; Wardelmann, Eva; Büttner, Reinhard; Weichert, Wilko; Dietel, Manfred; Schirmacher, Peter; Stenzinger, Albrecht; Pfarr, Nicole.
Afiliação
  • Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Glade J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Lehmann U; Institute of Pathology, University Hospital Hannover, Hannover, Germany.
  • Merkelbach-Bruse S; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
  • Hummel M; Institute of Pathology, Charité University Hospital, Berlin, Germany.
  • Lehmann A; Institute of Pathology, Charité University Hospital, Berlin, Germany.
  • Trautmann M; Institute of Pathology, University Hospital Münster, Münster, Germany.
  • Kumbrink J; Institute of Pathology, Ludwig Maximilian University (LMU), Munich, Germany.
  • Jung A; Institute of Pathology, Ludwig Maximilian University (LMU), Munich, Germany.
  • Dietmaier W; Institute of Pathology, University Hospital Regensburg, Regensburg, Germany.
  • Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Ploeger C; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Evert M; Institute of Pathology, University Hospital Regensburg, Regensburg, Germany.
  • Horst D; Institute of Pathology, Charité University Hospital, Berlin, Germany.
  • Kreipe H; Institute of Pathology, University Hospital Hannover, Hannover, Germany.
  • Kirchner T; Institute of Pathology, Ludwig Maximilian University (LMU), Munich, Germany.
  • Wardelmann E; Institute of Pathology, University Hospital Münster, Münster, Germany.
  • Büttner R; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
  • Weichert W; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.
  • Dietel M; Institute of Pathology, Charité University Hospital, Berlin, Germany.
  • Schirmacher P; Quality Assurance Initiative in Pathology (QuiP), Berlin, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Pfarr N; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Genes Chromosomes Cancer ; 59(8): 445-453, 2020 08.
Article em En | MEDLINE | ID: mdl-32319699
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas de Fusão Oncogênica / Testes Genéticos / Receptores Órfãos Semelhantes a Receptor Tirosina Quinase / RNA-Seq / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas de Fusão Oncogênica / Testes Genéticos / Receptores Órfãos Semelhantes a Receptor Tirosina Quinase / RNA-Seq / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha